Double-Tracer Dosimetry of Organs in Assessment of Bone Marrow Involvement by Two Monoclonal Antibodies

References

• Rosen S. T., Zimmer A. M., Goldman-Leikin R., et al. Radioimmunodetection and radioimmunotherapy of cutaneous T cell lymphomas using an 131I-labeled monoclonal antibody: an Illinois Cancer Council study. J Clin Oncol 1987; 5: 562–73
   PubMed Web of Science ®Google Scholar
• Stewart J. S. W., Hird V., Snook D., et al. Intraperitoneal 90Y-la-belled monoclonal antibody in ovarian cancer. J Clin Oncol 1990; 8: 1941–50
   PubMed Web of Science ®Google Scholar
• Kairemo K. J. A., Liewendahl K. Radioimmunodetection of malignant solid tumours. Scand J Clin Lab Invest 1994; 54: 569–83
   PubMed Web of Science ®Google Scholar
• Plaizier MABD, Roos J. C., Teule G. J. J., et al. Comparison of non-invasive approaches to red marrow dosimetry for radiola-belled monoclonal antibodies. Eur J Nucl Med 1994; 21: 216–22
   PubMedGoogle Scholar
• Eary J. F., Press O. W., Badger C. C., et al. Imaging and treatment of B-cell lymphoma. J Nucl Med 1990; 31: 1257–68
   PubMed Web of Science ®Google Scholar
• D'Addabbo A., Rubini G., Mele M., Lauriero F. A new method for assessing 99Tcm-MDP bone uptake from a bone scan image: quantitative measurement of radioactivity in global skeletal regions of interest. Nucl Med Commun 1992; 13: 55–60
   PubMed Web of Science ®Google Scholar
• Maclntyre W. J., Saha G. B., Go R. T. Planar imaging with single-head large-field-of-view cameras: are they still the workhorse. Semin Nucl Med 1994; 24: 11–6
   PubMed Web of Science ®Google Scholar
• O'Connell M. E. A., Flower M. A., Hinton P. J., Harmer C. L., Mc-Cready V. R. Radiation dose assessment in radioiodine therapy. Dose-response relationships in differentiated thyroid carcinoma using quantitative scanning and PET. Radiother Oncol 1993; 28: 16–26
   PubMed Web of Science ®Google Scholar
• Flower M. A., Schlesinger T., Hinton P. J., et al. Radiation dose assessment in radioiodine therapy. 2. Practical implementation using quantitative scanning and PET with initial results on thyroid carcinoma. Radiother Oncol 1989; 15: 345–57
   PubMed Web of Science ®Google Scholar
• Bajc M., Palmer J., Ohlsson T., Edenbrandt L. Distribution and dosimetry of 111In DTPA-D-Phe-octreotide in man assessed by whole body scintigraphy. Acta Radiol 1994; 35: 53–7
   PubMed Web of Science ®Google Scholar
• Buijs WCAM, Massuger LFAG, Claessens RAMJ, Kenemans P., Corstens F. H. M. Dosimetric evaluation of immunoscintigraphy using indium-Ill-labeled monoclonal antibody fragments in patients with ovarian cancer. J Nucl Med 1992; 33: 1113–20
   PubMed Web of Science ®Google Scholar
• Taube T., Elomaa I., Blomqvist C., Beneton M. N. C., Kanis J. A. Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancer. Bone 1994; 15: 161–6
   PubMed Web of Science ®Google Scholar
• Duncker C. M., Carrió I, Berná L, et al. Radioimmune imaging of bone marrow in patients with suspected bone metastases from primary breast cancer. J Nucl Med 1990; 31: 1450–5
   PubMed Web of Science ®Google Scholar
• Rieker O., Grünwald F., Layer G., et al. Disseminated bone marrow metastases from primary breast cancer: Detection and follow-up by radioimmune bone marrow scintigraphy. J Nucl Med 1994; 35: 1485–7
   PubMed Web of Science ®Google Scholar
• Snyder W. S., Fisher H. L., Jr, Ford M. R., Warner G. G. Estimates of absorbed fractions for monoenergetic photon sources uniformly distributed in various organs of a heterogeneous phantom. MIRD Pamphlet no 5. J Nucl Med 1969; 10((Suppl 3))7–52
   Google Scholar
• Mirdose 3. Radiation Internal Dose Information Center. Oak Ridge Institute for Science and Education, P. O. Box 117, Oak Ridge, TN 37831, USA
   Google Scholar
• Haddock G., Gray H. W., McKillop J. H., Bessent R. G. 99Tcm-nanocolloid bone marrow scintigraphy in prostatic cancer. Br J Urol 1989; 63: 497–502
   PubMedGoogle Scholar
• Bourgeois P., Gassavelis C., Malarme M., Feremans W., Frühling J. Bone marrow scintigraphy in breast cancer. Nucl Med Commun 1989; 10: 389–400
   PubMed Web of Science ®Google Scholar
• Sacchi S., Marietta M., Rinaldi D., et al. Bone and bone marrow scintigraphy in the diagnosis of metasplastic involvement of the skeletal system. J Nucl Med All Sci 1987; 31: 255–60
   PubMedGoogle Scholar
• Vogler JB, III, Murphy W. A. Bone marrow imaging. Radiology 1988; 168: 679–93
   PubMed Web of Science ®Google Scholar
• Reske S. N., Karstens J. H., Gloeckner W., et al. Radioim-munoimaging for diagnosis of bone marrow involvement in breast cancer and malignant lymphoma. Lancet 1989; 1: 299–301
   PubMed Web of Science ®Google Scholar
• Carpani de Kaski M., Peters A. M., Knight D., Stuttle A. W. J., Lavender J. P., Hodgson H. J. Indium-III whole-body retention: a method for quantification of disease activity in inflammatory bowel disease. J Nucl Med 1992; 33: 756–62
   PubMed Web of Science ®Google Scholar
• Peters A. M. The utility of [99mTc]HMPAO-leukocytes for imaging infection. Semin Nucl Med 1994; 24: 110–27
   PubMed Web of Science ®Google Scholar
• Meredith R. F., Khazaeli M. B., Plott W. E., et al. Phase I trial of iodine-131-chimeric B72.3 (human IgG4) in metastatic colorectal cancer. J Nucl Med 1992; 33: 23–9
   PubMed Web of Science ®Google Scholar